EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nitric Oxide Synthase 2 (NOS2) Gene Polymorphisms Association With Risk of Pulmonary Tuberculosis (PTB): A Case‐Control Study

Ebrahim Alijani iD, Mahboobeh Sabeti Akbar-Abad iD, Hossein Shahriari iD, Fatemeh Keykha iD, Mahdi Majidpour iD, Michael Faqih iD, Mohsen Taheri iD, Mahdi Atabaki iD

BioMed Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bmri/6656158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 25.02.2026. Verfasst von Ebrahim Alijani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran, zaums.ac.ir. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Nitric Oxide Synthase Type II. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zahedan University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary tuberculosis (PTB) remains a significant global health challenge, necessitating a deeper understanding of genetic factors influencing susceptibility. This study investigates the association between five specific polymorphisms in the nitric oxide synthase 2 (NOS2) genes (rs7215373, rs2297518, rs2274894, rs1800482, and rs9282799) and the risk of developing PTB.

Methods

Utilizing a case‐control design, we analyzed genetic samples from 150 PTB patients and 150 matched healthy controls. Genotyping was conducted using amplification refractory mutation system‐polymerase chain reaction (ARMS‐PCR) methods. Statistical analyses, including logistic regression and Hardy–Weinberg equilibrium tests, were performed to assess the associations between NOS2 polymorphisms and PTB risk.

Results

Our findings indicate that the rs7215373 and rs2274894 polymorphisms had no significant association with the risk of PTB. rs2297518 in the allelic model significantly reduced the risk by 0.50 against the occurrence of PTB ( p = 0.041). rs1800482 polymorphism in the Codominant 2 ( p = 0.041), recessive ( p = 0.043), and allelic ( p = 0.007) models reduced the risk of PTB by 0.85, 0.80, and 0.75, respectively. However, our results in examining the rs9282799 polymorphism showed that, contrary to previous results, the Codominant 1 ( p = 0.009), dominant ( p = 0.005), overdominant ( p = 0.012), and allelic ( p = 0.004) models increased the risk of PTB by 3.80, 3.75, 3.78, and 3.49, respectively.

Conclusion

These results suggest that specific NOS2 gene polymorphisms may play a role in modulating the immune response to Mycobacterium tuberculosis , highlighting their potential as biomarkers for PTB risk assessment. Further research is warranted to elucidate the underlying mechanisms and to explore the implications for targeted prevention strategies in high‐risk populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, PulmonaryGenetic Predisposition to DiseasePolymorphism, Single NucleotideNitric Oxide Synthase Type IIHumansCase-Control StudiesFemaleMaleMiddle AgedAdultRisk FactorsGenetic Association StudiesAllelesGene FrequencyGenotype

Stichwörter der Autor:innen

nitric oxide synthase 2 (NOS2)polymorphismpulmonary tuberculosis (PTB)

Substanzen

NOS2 protein, humanNitric Oxide Synthase Type II

Autor:innen und Institutionen

  • Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran, zaums.ac.ir.
  • Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran, zaums.ac.ir.
  • Cellular and Molecular Research Centre, Birjand University of Medical Sciences, Birjand, Iran, bums.ac.ir.
  • Department of Biology, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran, usb.ac.ir.
  • Student Research Committee, Zahedan University of Medical Sciences, Zahedan, Iran, zaums.ac.ir.
  • Genetics of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran, zaums.ac.ir.

ORCID-Profile: Ebrahim Alijani, Mahboobeh Sabeti Akbar-Abad, Hossein Shahriari, Fatemeh Keykha, Mahdi Majidpour, Michael Faqih, Mohsen Taheri, Mahdi Atabaki

Förderung

  • Zahedan University of Medical Sciences

Zitieren

APA

Alijani, E., Sabeti Akbar-Abad, M., Shahriari, H., Keykha, F., Majidpour, M., Faqih, M., Taheri, M., & Atabaki, M. (2026). Nitric Oxide Synthase 2 (NOS2) Gene Polymorphisms Association With Risk of Pulmonary Tuberculosis (PTB): A Case‐Control Study. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/6656158

Vancouver

Alijani E, Sabeti Akbar-Abad M, Shahriari H, Keykha F, Majidpour M, Faqih M, et al. Nitric Oxide Synthase 2 (NOS2) Gene Polymorphisms Association With Risk of Pulmonary Tuberculosis (PTB): A Case‐Control Study. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/6656158

BibTeX
@article{Alijani2026,
  author = {Alijani, Ebrahim and Sabeti Akbar-Abad, Mahboobeh and Shahriari, Hossein and Keykha, Fatemeh and Majidpour, Mahdi and Faqih, Michael and Taheri, Mohsen and Atabaki, Mahdi},
  title = {Nitric Oxide Synthase 2 (NOS2) Gene Polymorphisms Association With Risk of Pulmonary Tuberculosis (PTB): A Case‐Control Study},
  journal = {BioMed Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bmri/6656158}
}
Kostenlos starten →